EDT Pharmaceuticals and Par Pharmaceuticals Sue TWI Pharmaceuticals

  • September 7, 2011

EDT Pharmaceuticals and Par Pharmaceuticals filed suit against TWI Pharmaceuticals over a patent related to nanoparticulate megestrol formulations.  9/1, District of Maryland, 1:2011cv02466.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×